Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ala”

271 pharma patents match "ala" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 271
Index total 30,257
Page 5 / 12

Quick answer

This filtered view shows 271 pharmaceutical patents matching "ala" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

271 results for “ala” · 30,257 patents in full index Clear search

  1. US 10272139

    Process, tube and device for the preparation of wound healant composition

    RegenLab USA LLC · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  2. US 10265313

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  3. US 10253294

    Galactose oxidase treatment of dendritic cells to improve their immunogenicity

    Julius-Maximilians-Universitat Wurzburg · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  4. US 10251938

    Angiopoietin-based interventions for treating cerebral malaria

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  5. US 10226516

    Process, tube and device for the preparation of wound healant composition

    RegenLab USA LLC · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  6. US 10221408

    Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  7. US 10213389

    Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride

    RECRO GAINESVILLE LLC · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  8. US 10197577

    Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  9. US 10160802

    Anti-malarial compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  10. US 10154974

    Use of abscisic acid for the prevention and treatment of malaria

    The Regents of the University of California · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  11. CA 3065417

    TRAITEMENT DE MALADIES ASSOCIEES A UNE DYSREGULATION DE LA VOIE MTOR

    BIOCODEX [FR] · Granted Dec 6, 2018 · Expires Dec 1, 2038

    granted

  12. US 10119143

    Compositions and methods for inhibiting expression of the ALAS1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  13. US 10111957

    Inhalation compositions comprising glucose anhydrous

    ARVEN ILAC SANAYI VE TICARET A.S. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  14. US 10105316

    Inhalation compositions comprising muscarinic receptor antagonist

    ARVEN ILAC SANAYI VE TICARET A.S. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  15. US 10076505

    Inhalation formulations of Treprostinil

    United Therapeutics Corporation · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  16. US 10034866

    Inhalable medicament comprising tiotropium

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  17. US 9974796

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 22, 2018 · Expires May 17, 2038

    granted

  18. US 9968653

    Angiopoietin-based interventions for treating cerebral malaria

    REGENERON PHARMACEUTICALS, INC. · Granted May 15, 2018 · Expires May 10, 2038

    granted

  19. US 9962319

    One-component-type dentinal tubule sealant

    KURARAY NORITAKE DENTAL INC. · Granted May 8, 2018 · Expires May 3, 2038

    granted

  20. US 9938516

    Non-natural amino acid tRNA synthetases for para-methylazido-L-phenylalanine

    Sutro Biopharma, Inc. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  21. US 9918989

    Combination therapies for malaria

    The Regents of the University of California · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted

  22. WO 2017194692

    DERIVES DE LA BENZOXAZINE OU DE LA QUINAZOLINE POUR LEUR UTILISATION DANS LE TRAITEMENT DE LA MALADIE D'ALZHEIMER

    BIOCODEX [FR] · Granted Nov 16, 2017 · Expires Nov 11, 2037

    granted

  23. US 9808458

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  24. US 9796756

    Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA

    Arrowhead Pharmaceuticals, Inc. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.